RIVM European Reference Lab for vector-borne infections The European Commission (EC) has designated RIVM as the current European Reference Lab (EURL) for vector-borne viral pathogens.
In 2023 more Dutch people play sports on a weekly basis In 2023, 56% of the Dutch population aged four and over played sports at least once a week. This figure marks an increase from 53% in 2022. Notably, the percentage of individuals with physical disabilities who played sports weekly saw a significant rise, from 23% to 29%.
More than 2.7 million COVID-19 vaccinations administered in the 2023 autumn round In the 2023 autumn round, more than 2,731,000 people in the Netherlands received a COVID-19 vaccination. Vaccination coverage for people over 60 is currently 50.5%. Vaccination coverage varies by age group and region. COVID-19 vaccination was available until 22 December 2023.
Booster vaccinations reduced risk of death from COVID-19 in 2022 Booster vaccinations reduced the risk of dying from COVID-19 in 2022. The risk of death from other causes was also lower for people who had a booster jab than for people without a booster jab. These findings are from research by RIVM.
COVID-19 pandemic made me miss out on a key stage of my life, young people claim Young people aged 12–25 feel that the COVID-19 pandemic made them miss out on a key stage of their lives. They have indicated that important milestones, such as graduation ceremonies or the start of student life, passed them by. This is evident from the latest quarterly study conducted by the Network for Health Research in Disasters.
Vulnerable groups hit hardest by COVID-19 pandemic A new RIVM study has shown that the COVID-19 pandemic intensified existing socio-economic differences. People on lower incomes visited test lanes less often during the pandemic, but were admitted to hospital and intensive care with COVID-19 more often.
Number of Combined Lifestyle Intervention participants more than doubles in one year The number of participants that has started the Combined Lifestyle Intervention (CLI) has more than doubled over the course of a single year. Nationwide, over 82,000 people have now started the CLI. According to RIVM’s annual report, most of the participants achieve a good outcome.
Predicting who will experience symptoms after Lyme disease remains challenging Each year, approximately 27,000 people are diagnosed with Lyme disease. For most, the symptoms disappear after treatment with antibiotics. Unfortunately, 25% of those treated have chronic symptoms, such as fatigue, concentration disorders or pain.
Adherence to Physical Activity Guidelines particularly low among young adults The number of people in the Netherlands aged four and over who meet the Physical Activity Guidelines has fallen since 2020. In 2022, 44.3% of the population was sufficiently physically active.
New Zoonoses Report out now: avian flu most notable outbreak in 2022 Throughout 2022, the Netherlands faced a persistent avian flu outbreak, affecting 76 poultry farms. The virus also infected numerous wild birds and various wild mammals. These findings are presented in the Zoonoses Report, an annual publication issued jointly by RIVM and the Netherlands Food and Consumer Product Safety Authority (NVWA).